Skip to main content
SpringerLink
Log in

Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Thirty-four patients with moderate-severe hirsutism were enrolled in this study. The patients received 125 mg/day flutamide for a period of 6 months. Hirsutism score and hormone parameters including FSH, LH, T, free T, androste-nedione (A), DHEAS, PRL and sex hormone-binding globulin (SHBG) levels were evaluated in all patients before treatment and repeated at every three-monthly intervals. Hirsutism greatly improved during flutamide therapy, and the hirsutism score significantly decreased at month 3 and 6 from a mean (±SD) of 17.19±4.55 to 10.75±3.84 (p<0.001) and 17.19±4.55 to 5.91±2.53 (p<0.001), respectively. A significant reduction in hirsutism score (mean%±SD) as compared to baseline was observed at 3 months (37.78±13.30, p<0.001) and at 6 months (65.47±13.49, p<0.001). No significant changes in the levels of hormone and no serious side effects were observed in the patients. The lower dose flutamide, 125 mg/day, is a safe and cost-effective drug in the treatment of hirsutism. Lower dose flutamide may be used in place of high dose flutamide, 250 to 750 mg/day.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Krischner M.A., Bardin C.W. Androgen production and metabolism in normal and virilized women. Metabolism 21: 667, 1972.

    Article  Google Scholar 

  2. Biffignandi P., Massuchetti C., Molinatti G.M. Female hirsutism: Pathophysiological considerations and therapeutic implications. Endocr. Rev. 5: 498, 1984.

    Article  CAS  PubMed  Google Scholar 

  3. Tremblay R.R. Treatment of hirsutism with spironolactone. J. Clin. Endocrinol. Metab. 5: 363, 1986.

    Article  Google Scholar 

  4. Belisle L., Love E.J. Clinical efficacy and safety of cyproterone acetate in severe hirsutism: Results of a multicentered Canadian study. Fertil. Steril. 46: 1015, 1986.

    CAS  PubMed  Google Scholar 

  5. Dodin S., Faure N., Cedrin I., Mechain C., Turcot-Lemay L., Guy J., Lemay A. Clinical efficacy and safety of low-dose flutamide alone and combined with an oral contraceptive for the treatment of idiopathic hirsutism. Clin. Endocrinol. (Oxf.) 43: 575, 1995.

    Article  CAS  Google Scholar 

  6. Neri R., Kassem N. Biological and clinical properties of antiandrogens. Progress in Cancer Research and Therapy 31: 507, 1984.

    CAS  Google Scholar 

  7. Moghetti P., Castello R., Negri C., Tosi F., Magnani C.M., Fontanarosa M.C., Armanini D., Muggeo M. Flutamide in the treatment of hirsutism: long-term clinical effects, endocrine changes, and androgen receptor behavior. Fertil. Steril. 64: 511, 1995.

    CAS  PubMed  Google Scholar 

  8. Cesur V., Kamel N., Uysal A.Z., Erdoğan G., Başkal N. The use of antiandrogen flutamide in the treatment of hirsutism. Endocr. J. 41: 573, 1994.

    Article  CAS  PubMed  Google Scholar 

  9. Marcondes J.A.M., Minnani S.L., Luthold W.W., Bernardo L.W., Samojlik E., Kirschner M.A. Treatment of hirsutism in women with flutamide. Fertil. Steril. 57: 543, 1992.

    CAS  PubMed  Google Scholar 

  10. Müderris I.I., Bayram F., Şahin Y., Keleştimur F., Tutuş A., Ayata D. The efficacy of 250 mg/day flutamide in the treatment of patients with hirsutism. Fertil. Steril. 66: 220, 1996.

    PubMed  Google Scholar 

  11. Hatch R., Rosenfield R., Kim M.H., Tredway D. Hirsutism: implications, etiology, and managment. Am. J. Obstet. Gynecol. 140: 815, 1981.

    CAS  PubMed  Google Scholar 

  12. Falsetti L., De Fusco D., Eleftheriou G., Rosina B. Treatment of hirsutism by finasteride and flutamide in women with polycystic ovary sydrome. Gynecol. Endocrinol. 11: 251, 1997.

    Article  CAS  PubMed  Google Scholar 

  13. Erenus M., Gürbüz O., Durmuşoğlu F., Demirçay Z., Pekin S. Comparison of the efficacy of spironolactone versus flutamide in the treatment of hirsutism. Fertil. Steril. 61: 613, 1994.

    CAS  PubMed  Google Scholar 

  14. Cusan L., Dupont A., Gomez J.-L., Tremblay R.R., Labrie F. Comparison of flutamide and spironolactone in the treatment of hirsutism: A randomized controlled trial. Fertil. Steril. 61: 28, 1994.

    Google Scholar 

  15. Moller S., Iversen P., Franzmann M.B. Flutamide-induced liver failure. J. Hepatol. 10: 346, 1990.

    Article  CAS  PubMed  Google Scholar 

  16. Wysdwski D.K., Freiman J.P., Tourtelot J.B., Horton M.L. Fatal and nonfatal hepatotoxicity associated with flutamide. Ann. Intern. Med. 118: 860, 1993.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Obstetrics and Gynecology, Erciyes University, Faculty of Medicine, 38039, Kayseri, Turkey

    I. I. Müderris M.D.

  2. Department of Endocrinology, Erciyes University, Faculty of Medicine, Kayseri, Turkey

    F. Bayram

Authors
  1. I. I. Müderris M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F. Bayram
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Müderris, I.I., Bayram, F. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism. J Endocrinol Invest 22, 165–168 (1999). https://doi.org/10.1007/BF03343536

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03343536

Key-words

Search

Navigation